Literature DB >> 5576165

Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts.

M T Porter, A L Fluharty, H Kihara.   

Abstract

Cultured fibroblasts derived from patients with late infantile metachromatic leukodystrophy incorporated arylsulfatase A from the growth medium. Upon exposure to cerebroside sulfate, they exhibited patterns of uptake and hydrolysis indistinguishable from cells derived from control subjects. Furthermore, inclusion granules formed in the metachromatic leukodystrophy fibroblasts upon exposure to sulfatides were cleared by subsequent supplementation of the growth medium with arylsulfatase A.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576165     DOI: 10.1126/science.172.3989.1263

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

Review 1.  Replacement therapy in the mucopolysaccharidoses.

Authors:  M F Dean
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 2.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

Review 3.  New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

Review 4.  Inborn errors of metabolism: principles and their applications.

Authors:  L Pinksy
Journal:  Can Med Assoc J       Date:  1972-03-18       Impact factor: 8.262

5.  Simplified procedure for preparation of 35S-labeled brain sulfatide.

Authors:  A L Fluharty; M L Davis; H Kihara; G Kritchevsky
Journal:  Lipids       Date:  1974-11       Impact factor: 1.880

6.  The correction of Hunter fibroblasts by exogenous iduronate sulfate sulfatase: biochemical and ultrastructural studies.

Authors:  R Eliahu; E Sekeles; R Cohen; G Bach
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

7.  Sphingolipidoses.

Authors:  K Sandhoff
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

Review 8.  Neural stem cell transplantation as a therapeutic approach for treating lysosomal storage diseases.

Authors:  Lamya S Shihabuddin; Seng H Cheng
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 9.  Enzyme replacement and enhancement therapies for lysosomal diseases.

Authors:  R J Desnick
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Bone marrow transplants in genetic diseases.

Authors:  J R Hobbs
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.